- Home
- COMM vs VKTX Comparison
COMM vs VKTX Comparison
Compare COMM & VKTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- COMM
- VKTX
- Stock Information
- Founded
- COMM 1976
- VKTX 2012
- Country
- COMM United States
- VKTX United States
- Employees
- COMM N/A
- VKTX N/A
- Industry
- COMM Radio And Television Broadcasting And Communications Equipment
- VKTX Biotechnology: Pharmaceutical Preparations
- Sector
- COMM Technology
- VKTX Health Care
- Exchange
- COMM Nasdaq
- VKTX Nasdaq
- Market Cap
- COMM 3.4B
- VKTX 3.0B
- IPO Year
- COMM 2013
- VKTX 2015
- Fundamental
- Price
- COMM $15.18
- VKTX $31.60
- Analyst Decision
- COMM Hold
- VKTX Strong Buy
- Analyst Count
- COMM 5
- VKTX 12
- Target Price
- COMM $12.38
- VKTX $86.42
- AVG Volume (30 Days)
- COMM 5.3M
- VKTX 5.3M
- Earning Date
- COMM 11-06-2025
- VKTX 10-22-2025
- Dividend Yield
- COMM N/A
- VKTX N/A
- EPS Growth
- COMM N/A
- VKTX N/A
- EPS
- COMM 3.34
- VKTX N/A
- Revenue
- COMM $4,751,500,000.00
- VKTX N/A
- Revenue This Year
- COMM $28.73
- VKTX N/A
- Revenue Next Year
- COMM $8.90
- VKTX N/A
- P/E Ratio
- COMM $4.51
- VKTX N/A
- Revenue Growth
- COMM 20.87
- VKTX N/A
- 52 Week Low
- COMM $2.94
- VKTX $18.92
- 52 Week High
- COMM $17.13
- VKTX $81.73
- Technical
- Relative Strength Index (RSI)
- COMM 44.61
- VKTX 62.28
- Support Level
- COMM $15.08
- VKTX $25.04
- Resistance Level
- COMM $16.28
- VKTX $26.96
- Average True Range (ATR)
- COMM 0.61
- VKTX 1.67
- MACD
- COMM -0.22
- VKTX 1.00
- Stochastic Oscillator
- COMM 12.69
- VKTX 88.05
About COMM CommScope Holding Company Inc.
CommScope Holding Co Inc is a provider of infrastructure solutions for communication, data center, and entertainment networks. The company provides solutions for wired and wireless networks to enable service providers, including cable, telephone, data center, and digital broadcast satellite operators and media programmers, to deliver media, voice, Internet Protocol (IP) data services, and Wi-Fi to their subscribers and allow enterprises to experience constant wireless and wired connectivity across complex and varied networking environments. The company's operating segments are: Connectivity and Cable Solutions (CCS), Networking, Intelligent Cellular and Security Solutions (NICS), and Access Network Solutions (ANS).
About VKTX Viking Therapeutics Inc.
Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.